Yifeng Pharmacy Chain Co., Ltd.

SSE:603939.SS

25.02 (CNY) • At close June 13, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q1
Revenue 6,009.0446,843.2575,456.4975,766.4055,947.7866,668.455,181.4845,440.515,266.0536,538.7584,597.6044,601.5394,148.4944,388.3163,591.6143,716.5963,629.7793,707.8593,143.7843,244.9013,047.9582,887.4282,340.4742,578.8432,469.432,246.9211,672.3181,511.7051,481.6321,388.261,180.3881,160.3471,078.2541,061.147909.84929.089833.544867.034675.631663.319639.532636.511552.342544.989496.384
Cost of Revenue 3,627.1934,144.4743,212.2243,543.8613,627.5854,461.0963,179.8283,247.3733,177.3654,141.2742,710.1522,724.2792,449.8592,704.7972,091.7172,188.1862,158.1182,347.5531,908.0332,012.3681,884.1171,806.7211,385.871,580.1441,494.8581,389.637997.859891.311887.275839.744695.635696.966650.239638.498544.345567.449504.172542.254410.086394.423382.397383.441332.322331.043296.425
Gross Profit 2,381.8512,698.7832,244.2722,222.5442,320.2012,207.3542,001.6562,193.1372,088.6882,397.4841,887.4521,877.261,698.6351,683.5191,499.8971,528.411,471.6611,360.3071,235.751,232.5331,163.8411,080.707954.603998.699974.572857.284674.459620.394594.357548.516484.753463.381428.016422.648365.495361.64329.371324.78265.545268.895257.136253.07220.02213.946199.96
Gross Profit Ratio 0.3960.3940.4110.3850.390.3310.3860.4030.3970.3670.4110.4080.4090.3840.4180.4110.4050.3670.3930.380.3820.3740.4080.3870.3950.3820.4030.410.4010.3950.4110.3990.3970.3980.4020.3890.3950.3750.3930.4050.4020.3980.3980.3930.403
Reseach & Development Expenses 6.8228.753.0372.9669.77214.0025.3995.224.63711.544.5695.0264.1756.6693.2983.0482.6282.5011.9831.9531.8742.6560.9050.3671.4433.2380.086002.32.321.763014.78900000000000
General & Administrative Expenses 279.18-608.89685.202-178.173249.116-530.317597.012-132.684214.581-424.442525.175-140.97172.962-396.169441.522-105.747143.408-290.893131.54-77.705112.872-268.197119.232-72.71894.715-136.97558.318-51.57362.569-124.56947.778-37.83143.246-97.04640.294-27.76832.874-76.82129.458-23.65828.597-69.40726.40427.90623.095
Selling & Marketing Expenses 1,413.764-3,255.8923,942.5671,548.6621,456.9251,435.1481,300.6781,403.461,348.1651,318.131,281.6781,200.481,077.9851,166.2021,011.298947.621934.563938.627806.586737.174747.125783.381641.975623.498632.408613.176483.068418.007381.722359.01340.098303.506291.574290.073260.586243.938221.452222.77188.414181.063166.214161.764150.229136.371128.87
SG&A 1,692.944-3,864.7834,627.7691,669.0091,702.9321,614.8921,897.6891,270.7761,562.746893.6891,806.8531,059.511,250.947770.0331,452.82841.8741,077.971647.734938.126659.469859.997515.184761.207550.78727.123476.201541.386366.434444.291234.441387.876265.674334.82193.027300.881216.17254.326145.95217.872157.405194.81192.358176.633164.277151.965
Other Expenses 31.5435,936.536-2,843.393-19.496-19.302-24.1160.018-0.193-5.288787.759-324.113336.753-2.67-0.9760.736-1.9481.226-2.867-1.161-2.1310.039-0.341-0.969-0.8150.952-0.051.7280.0931.17-4.664-0.8485.3471.0735.5030.313.0730.8131.7942.9822.1060.1491.4822.0062.2011.022
Operating Expenses 1,731.3092,080.5031,792.6951,691.471,732.0061,653.011,534.3271,660.6581,562.0951,692.9871,487.3091,401.2891,252.4521,343.3981,186.7641,116.1181,079.5271,108.344938.819872.72860.444901.205766.532742.265734.553712.792553.969478.318448.998420.971397.368360.852341.901345.724306.663283.579259.84260.431222.86213.678199.907192.868181.949168.697155.968
Operating Income 650.542618.28448.142531.074588.195554.343436.085531.077501.654668.16366.929443.126407.317307.175286.806385.083359.804271.953273.843335.963288.276188.479171.036235.125220.828151.634117.045165.821143.823130.04791.221111.01394.90983.93264.35877.69870.64368.36347.52360.6756.30458.59637.93445.32442.972
Operating Income Ratio 0.1080.090.0820.0920.0990.0830.0840.0980.0950.1020.080.0960.0980.070.080.1040.0990.0730.0870.1040.0950.0650.0730.0910.0890.0670.070.110.0970.0940.0770.0960.0880.0790.0710.0840.0850.0790.070.0910.0880.0920.0690.0830.087
Total Other Income Expenses Net -2.713-15.8250.354-2.187-0.28415.4470.018-0.193-0.837-10.394-0.4512.837-0.037-0.9760.736-1.9481.226-2.867-2.279-2.131-6.653-0.341-0.969-0.8150.952-0.051.7280.0931.17-3.985-2.1415.0760.8945.3310.2012.9950.6861.6042.8832.1540.1011.3891.9852.1850.929
Income Before Tax 647.829602.455448.496538.259593.239569.472436.103530.884500.817657.766366.478445.963407.28306.199287.542383.135361.03269.086272.682333.832288.315188.138170.067234.31221.78151.583118.773165.914144.994126.06290.254116.08995.69389.26364.55980.69371.32969.96750.40662.82456.40459.98439.9247.50943.902
Income Before Tax Ratio 0.1080.0880.0820.0930.10.0850.0840.0980.0950.1010.080.0970.0980.070.080.1030.0990.0730.0870.1030.0950.0650.0730.0910.090.0670.0710.110.0980.0910.0760.10.0890.0840.0710.0870.0860.0810.0750.0950.0880.0940.0720.0870.088
Income Tax Expense 154.28148.091110.148124.139147.286117.128106.697111.892120.947147.09790.489107.273105.43484.16873.52898.21591.24666.13672.12985.93672.8646.60343.93959.06555.80531.0230.76538.89439.01631.93223.76929.41925.50823.46116.41619.76118.28718.46412.55715.47814.86515.36810.41411.611.53
Net Income 449.494418.076312.783390.965406.753412.801294.03368.676336.477442.011247.174304.197272.228191.928191.206263.456241.295177.786178.217221.419186.492125.437110.288160.856147.169107.65583.555124.246100.95893.31865.38785.44569.35464.52547.26459.82652.27650.67537.38546.75141.12543.9729.13535.34932.107
Net Income Ratio 0.0750.0610.0570.0680.0680.0620.0570.0680.0640.0680.0540.0660.0660.0440.0530.0710.0660.0480.0570.0680.0610.0430.0470.0620.060.0480.050.0820.0680.0670.0550.0740.0640.0610.0520.0640.0630.0580.0550.070.0640.0690.0530.0650.065
EPS 0.370.3450.260.320.40.410.290.370.330.440.350.420.380.160.280.380.250.260.190.320.190.180.110.230.150.160.0880.190.110.140.0710.130.0750.10.0510.10.0640.0870.0510.0960.0630.10.0480.0810.053
EPS Diluted 0.360.2970.260.320.40.410.290.370.330.440.350.420.380.160.280.380.240.260.190.320.190.180.110.230.150.160.0880.190.110.140.0710.130.0750.10.0510.10.0640.0870.0510.0960.0630.10.0480.0810.053
EBITDA 702.5041,228.9811,070.0921,105.6601,097.362968.226997.312966.6951,117.523837.005858.702815.945693.579674.342731.301716.289345.638300.362351.813304.274249.058184.999249.649233.123158.429134.557166.105157.891155.82587.385105.99288.077116.93658.83182.36871.77264.34842.68555.21858.84962.74338.07145.24945.307
EBITDA Ratio 0.1170.180.1960.19200.1650.1870.1830.1840.1710.1820.1870.1970.1580.1880.1970.1970.0930.0960.1080.10.0860.0790.0970.0940.0710.080.110.1070.1120.0740.0910.0820.110.0650.0890.0860.0740.0630.0830.0920.0990.0690.0830.091